Affiliation:
1. School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia Cancer Research Institute, Adelaide, South Australia 5001, Australia
Abstract
Poor profiles of potential drug candidates, including pharmacokinetic properties, have been
acknowledged as a significant hindrance to the development of modern therapeutics. Contemporary drug
discovery and development would be incomplete without the aid of molecular modeling (in-silico) techniques,
allowing the prediction of pharmacokinetic properties such as clearance, unbound fraction,
volume of distribution and bioavailability. As with all models, in-silico approaches are subject to their
interpretability, a trait that must be balanced with accuracy when considering the development of new
methods. The best models will always require reliable data to inform them, presenting significant challenges,
particularly when appropriate in-vitro or in-vivo data may be difficult or time-consuming to obtain.
This article seeks to review some of the key in-silico techniques used to predict key pharmacokinetic
properties and give commentary on the current and future directions of the field.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献